Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia [Phase 2]

View source ↗

Summary

Phase 2 randomized trial assessing E2006 for chronic insomnia in adults and elderly, with Bayesian adaptive design; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• E2006

Snippet

Sponsor: Eisai Inc. | Conditions: Chronic Insomnia, Adults | Phase 2 | Status: COMPLETED | Results posted: 2020-01-31